TICKERNOMICS Sign up
Last Update: 2024-03-28 02:14:52
Science 37 Holdings Inc. ( SNCE ) https://www.science37.com
5.75USD
Sector:
Healthcare
Industry:
Health Information Services
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
SNCE
5.70%
SPY
32.74%
-97.24%
SNCE
SPY
92.93%
SNCE
0.00%
SPY
224.41%
SNCE
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
679.34
623.51
0.00
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-5.50
11.27
13.13
-8.81
0.00
-9.37
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-97.70
39.73
-112.35
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
-71.31
-72.32
0.00
Other Earnings and Cash Flow Stats:
Science 37 Holdings Inc. ( SNCE ) Net Income TTM ($MM) is -123.99
Science 37 Holdings Inc. ( SNCE ) Operating Income TTM ($MM) is -34.11
Science 37 Holdings Inc. ( SNCE ) Owners' Earnings Annual ($MM) is 0.00
Science 37 Holdings Inc. ( SNCE ) Current Price to Owners' Earnings ratio is 0.00
Science 37 Holdings Inc. ( SNCE ) EBITDA TTM ($MM) is -28.65
Science 37 Holdings Inc. ( SNCE ) EBITDA Margin is -112.35%
Capital Allocation:
Science 37 Holdings Inc. ( SNCE ) has paid 0.00 dividends per share and bought back -2.27 million shares in the past 12 months
Science 37 Holdings Inc. ( SNCE ) has reduced its debt by 0.741 million USD in the last 12 months
Capital Structure:
Science 37 Holdings Inc. ( SNCE ) Interest-bearing Debt ($MM) as of last quarter is 0
Science 37 Holdings Inc. ( SNCE ) Annual Working Capital Investments ($MM) are 15
Science 37 Holdings Inc. ( SNCE ) Book Value ($MM) as of last quarter is 51
Science 37 Holdings Inc. ( SNCE ) Debt/Capital as of last quarter is 1%
Other Balance Sheet Stats:
Science 37 Holdings Inc. ( SNCE ) has 56 million in cash on hand as of last quarter
Science 37 Holdings Inc. ( SNCE ) has 18 million of liabilities due within 12 months, and long term debt 0 as of last quarter
Science 37 Holdings Inc. ( SNCE ) has 118 common shares outstanding as of last quarter
Science 37 Holdings Inc. ( SNCE ) has 0 million USD of preferred stock value
Academic Scores:
Science 37 Holdings Inc. ( SNCE ) Altman Z-Score is 10.01 as of last quarter
Science 37 Holdings Inc. ( SNCE ) Piotroski Score is 3.00 as of last quarter
Corporate Governance:
Science 37 Holdings Inc. ( SNCE ) largest shareholder is State Street Corporation owning 197278 shares at 1.13 ($MM) value
Christine A Pellizzari(an insider) Bought 250 shares of Science 37 Holdings Inc. ( SNCE ) for the amount of $4050.00 on 2022-11-17
18.49% of Science 37 Holdings Inc. ( SNCE ) is held by insiders, and 55.64% is held by institutions
Science 37 Holdings Inc. ( SNCE ) went public on 2020-11-20
Other Science 37 Holdings Inc. ( SNCE ) financial metrics:
FCF:-74.46
Unlevered Free Cash Flow:-107.70
EPS:-0.47
Operating Margin:-97.70
Gross Profit Margin:39.73
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-107.64
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Science 37 Holdings Inc. ( SNCE ) :
Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.